Physician profile
Bert R Mandelbaum
NPI 1770673840
$52,229.13
in general payments reported to CMS, 2019-2025
24 companies · $3,647 in 2025
The $3,647 reported for 2025 was more than what 77% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $387 · 2021: $15K · 2022: $6,552 · 2023: $3,914 · 2024: $10K · 2025: $3,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,575 · Food and Beverage: $3,830 · Honoraria: $3,000 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Travel and Lodging: $258 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,575.00 |
| Food and Beverage | $3,829.77 |
| Honoraria | $3,000.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Travel and Lodging | $257.86 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $29,024.21 | 2019-2023 | |
| Linvatec Corporation | $9,896.84 | 2023-2025 | Biobrace 23mm, Allograft Tissue |
| Averitas Pharma INC. | $4,179.33 | 2024 | |
| Micromed INC | $2,786.63 | 2021-2022 | |
| Smith+Nephew, INC. | $904.63 | 2024-2025 | Cap-Fix, N/A, Q-Fix |
| Depuy Synthes Products, INC. | $720.00 | 2021 | |
| Stryker Corporation | $650.35 | 2019-2023 | |
| Saxum Surgical, INC. | $642.72 | 2023-2024 | |
| Rti Surgical, INC | $570.47 | 2021-2022 | |
| Depuy Synthes Sales INC. | $396.45 | 2019-2024 | Dynacord, Twistr, Na |
| Aesculap Biologics, LLC | $355.73 | 2019-2021 | |
| Djo, LLC | $317.57 | 2021-2024 | Procare, Donjoy, Aircast |
| Vericel Corporation | $299.97 | 2024-2025 | Maci |
| Joint Restoration Foundation, INC. | $267.63 | 2021-2024 | |
| Bioventus LLC | $262.00 | 2019-2023 | Gelsyn-3, Durolane |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $250.18 | 2020 | |
| Ossio INC | $143.39 | 2023 | |
| Overture Orthopaedics | $140.68 | 2025 | Overtureti |
| Medical Device Business Services, INC. | $132.68 | 2019-2021 | |
| Catalyst Orthoscience | $84.37 | 2021 | |
| Ferring Pharmaceuticals INC. | $72.94 | 2019 | |
| Pacira Therapeutics, INC. | $66.55 | 2019 | |
| Avanos Medical | $41.45 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$55,778.24 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bert Mandelbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.